$Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.$

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.

BACKGROUND: We investigated the association of different subfractions of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2), such as total PSA (tPSA), complexed PSA (cPSA), free PSA (fPSA), "single-chain Intact fPSA" (fPSA-I), "multi-chain nicked fPSA" (fPSA-...

Podrobná bibliografie
Hlavní autoři:	Steuber, T, Niemela, P, Haese, A, Pettersson, K, Erbersdobler, A, Felix Chun, K, Graefen, M, Kattan, M, Huland, H, Lilja, H
Médium:	Journal article
Jazyk:	English
Vydáno:	2005

Podobné jednotky

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
Autor: Haese, A, a další
Vydáno: (2003)

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
Autor: Haese, A, a další
Vydáno: (2003)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Autor: Steuber, T, a další
Vydáno: (2002)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
Autor: Haese, A, a další
Vydáno: (2003)

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Autor: Haese, A, a další
Vydáno: (2001)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
Autor: Haese, A, a další
Vydáno: (2000)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
Autor: Nurmikko, P, a další
Vydáno: (2002)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Autor: Haese, A, a další
Vydáno: (2005)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Autor: Steuber, T, a další
Vydáno: (2006)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Autor: Steuber, T, a další
Vydáno: (2007)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
Autor: Becker, C, a další
Vydáno: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
Autor: Becker, C, a další
Vydáno: (2003)

Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.
Autor: Ylikoski, A, a další
Vydáno: (2002)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
Autor: Cao, Y, a další
Vydáno: (2002)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
Autor: Haese, A, a další
Vydáno: (2004)

Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
Autor: Ylikoski, A, a další
Vydáno: (2001)

[Isoforms of free prostate-specific antigen]
Autor: Haese, A, a další
Vydáno: (2004)

Isoforms of free prostate-specific antigen
Autor: Haese, A, a další
Vydáno: (2004)

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Autor: Becker, C, a další
Vydáno: (2000)

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
Autor: Olsson, A, a další
Vydáno: (2004)

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
Autor: Becker, C, a další
Vydáno: (2000)

Standardization of two immunoassays for human glandular kallikrein 2.
Autor: Haese, A, a další
Vydáno: (2003)

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Autor: Piironen, T, a další
Vydáno: (2006)

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.
Autor: Väisänen, V, a další
Vydáno: (2006)

Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.
Autor: Becker, C, a další
Vydáno: (2000)

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
Autor: Olsson, A, a další
Vydáno: (2005)

Prediction of tumor heterogeneity in localized prostate cancer.
Autor: Huland, H, a další
Vydáno: (2002)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
Autor: Becker, C, a další
Vydáno: (2001)

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
Autor: Siivola, P, a další
Vydáno: (2000)

Development of sensitive immunoassays for free and total human glandular kallikrein 2.
Autor: Väisänen, V, a další
Vydáno: (2004)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
Autor: Steuber, T, a další
Vydáno: (2007)

Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
Autor: Janssen, S, a další
Vydáno: (2004)

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
Autor: Wenske, S, a další
Vydáno: (2009)

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
Autor: Ulmert, D, a další
Vydáno: (2009)

Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Autor: Björk, T, a další
Vydáno: (2001)

The evolution of the glandular kallikrein locus: identification of orthologs and pseudogenes in the cotton-top tamarin.
Autor: Olsson, A, a další
Vydáno: (2004)

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.
Autor: Bruun, L, a další
Vydáno: (2004)

Bladder drainage and glandular epithelial morphometry of the prostate in benign prostatic hyperplasia with severe symptoms
Autor: Carlos A. Cury, a další
Vydáno: (2006-04-01)

Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.
Autor: Nurmikko, P, a další
Vydáno: (2001)

Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step.
Autor: Niemelä, P, a další
Vydáno: (2002)